Sugar L - Search Results

1

A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.

Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, Narod SA. Nam RK, et al. Among authors: sugar l. J Urol. 2006 Apr;175(4):1291-7. doi: 10.1016/S0022-5347(05)00695-6. J Urol. 2006. PMID: 16515983

2

Variation in patterns of practice in diagnosing screen-detected prostate cancer.

Nam RK, Toi A, Trachtenberg J, Jewett MA, Klotz L, Fleshner N, Bagnell PS, Sweet J, Sugar L, Narod SA. Nam RK, et al. Among authors: sugar l. BJU Int. 2004 Dec;94(9):1239-44. doi: 10.1111/j.1464-410X.2004.05150.x. BJU Int. 2004. PMID: 15610097

3

The use of genetic markers to determine risk for prostate cancer at prostate biopsy.

Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA. Nam RK, et al. Among authors: sugar l. Clin Cancer Res. 2005 Dec 1;11(23):8391-7. doi: 10.1158/1078-0432.CCR-05-1226. Clin Cancer Res. 2005. PMID: 16322300

4

Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.

Nam RK, Toi A, Trachtenberg J, Klotz LH, Jewett MA, Emami M, Sugar L, Sweet J, Pond GR, Narod SA. Nam RK, et al. Among authors: sugar l. J Urol. 2006 Feb;175(2):489-94. doi: 10.1016/S0022-5347(05)00159-X. J Urol. 2006. PMID: 16406978

5

Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.

Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Loblaw A, Pond GR, Emami M, Sugar L, Sweet J, Narod SA. Nam RK, et al. Among authors: sugar l. Can J Urol. 2006 Apr;13 Suppl 2:2-10. Can J Urol. 2006. PMID: 16672122

6

Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.

Nam RK, Zhang WW, Klotz LH, Trachtenberg J, Jewett MA, Sweet J, Toi A, Teahan S, Venkateswaran V, Sugar L, Loblaw A, Siminovitch K, Narod SA. Nam RK, et al. Among authors: sugar l. Clin Cancer Res. 2006 Nov 1;12(21):6452-8. doi: 10.1158/1078-0432.CCR-06-1485. Clin Cancer Res. 2006. PMID: 17085659

7

Assessing individual risk for prostate cancer.

Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW. Nam RK, et al. Among authors: sugar l. J Clin Oncol. 2007 Aug 20;25(24):3582-8. doi: 10.1200/JCO.2007.10.6450. J Clin Oncol. 2007. PMID: 17704405

8

Utility of incorporating genetic variants for the early detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Seth A, Klotz LH, Stanimirovic A, Punnen S, Venkateswaran V, Toi A, Loblaw DA, Sugar L, Siminovitch KA, Narod SA. Nam RK, et al. Among authors: sugar l. Clin Cancer Res. 2009 Mar 1;15(5):1787-93. doi: 10.1158/1078-0432.CCR-08-1593. Epub 2009 Feb 17. Clin Cancer Res. 2009. PMID: 19223501

9

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.

Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA. Nam RK, et al. Among authors: sugar l. J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13. J Urol. 2016. PMID: 26880413 Clinical Trial.

10

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

Nam RK, Sugar L, Wang Z, Yang W, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A. Nam RK, et al. Among authors: sugar l. Cancer Biol Ther. 2007 Jan;6(1):40-5. doi: 10.4161/cbt.6.1.3489. Cancer Biol Ther. 2007. PMID: 17172822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page